AU2003263585A1 - Amorphous duloxetine hydrochloride - Google Patents
Amorphous duloxetine hydrochlorideInfo
- Publication number
- AU2003263585A1 AU2003263585A1 AU2003263585A AU2003263585A AU2003263585A1 AU 2003263585 A1 AU2003263585 A1 AU 2003263585A1 AU 2003263585 A AU2003263585 A AU 2003263585A AU 2003263585 A AU2003263585 A AU 2003263585A AU 2003263585 A1 AU2003263585 A1 AU 2003263585A1
- Authority
- AU
- Australia
- Prior art keywords
- amorphous
- duloxetine hydrochloride
- duloxetine
- hydrochloride
- amorphous duloxetine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2003/000280 WO2005019199A1 (en) | 2003-08-25 | 2003-08-25 | Amorphous duloxetine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003263585A1 true AU2003263585A1 (en) | 2005-03-10 |
Family
ID=34204121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003263585A Abandoned AU2003263585A1 (en) | 2003-08-25 | 2003-08-25 | Amorphous duloxetine hydrochloride |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003263585A1 (en) |
WO (1) | WO2005019199A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776049A2 (en) * | 2005-01-27 | 2007-04-25 | Teva Pharmaceutical Industries Ltd. | Duloxetine hcl polymorphs |
WO2006099433A1 (en) | 2005-03-14 | 2006-09-21 | Teva Pharmaceutical Industries Ltd. | Pure duloxetine hydrochloride |
US7759500B2 (en) | 2005-12-05 | 2010-07-20 | Teva Pharmaceutical Industries Ltd. | 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride |
EP1820800A1 (en) | 2006-02-17 | 2007-08-22 | KRKA, tovarna zdravil, d.d., Novo mesto | Crystalline forms of duloxetine hydrochloride and processes for their preparation |
GB0612506D0 (en) | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
GB0612509D0 (en) | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
EP2040697A2 (en) * | 2006-07-03 | 2009-04-01 | Ranbaxy Laboratories Limited | Polymorphic form of duloxetine hydrochloride |
EP2558455B1 (en) | 2010-04-13 | 2017-08-09 | KRKA, D.D., Novo Mesto | Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
WO2003062219A1 (en) * | 2002-01-24 | 2003-07-31 | Eli Lilly And Company | Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine |
-
2003
- 2003-08-25 AU AU2003263585A patent/AU2003263585A1/en not_active Abandoned
- 2003-08-25 WO PCT/IN2003/000280 patent/WO2005019199A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005019199A1 (en) | 2005-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003272930A1 (en) | Footwere | |
AU2003902483A0 (en) | A bioelastomer ii | |
AU2003263585A1 (en) | Amorphous duloxetine hydrochloride | |
AU2003902474A0 (en) | A bioelastomer i | |
AU2003902882A0 (en) | Piperidyl derivatives | |
AU2003274573A1 (en) | Deburrer | |
GB0314149D0 (en) | Novel amorphous forms | |
AU2003278418A1 (en) | Amorphous moxifloxacin hydrochloride | |
AU2003234859A1 (en) | Description | |
AU2003304291A1 (en) | A car-locking device | |
AU2003241210A1 (en) | Videocomputer | |
AU2003211854A1 (en) | Putter | |
AU2003100325A4 (en) | Freez-A-Cube | |
AU2003100942A4 (en) | Energenz | |
AU2003100378A4 (en) | Scootermansydney | |
AU2003100198A4 (en) | Colourband Browbands | |
AU2003100006A4 (en) | Adcaster | |
AU152662S (en) | A hinge | |
AU157678S (en) | A hinge | |
AU157682S (en) | A hinge | |
AU2003248104A1 (en) | Crystalline 6-n-pyridylmethylaminoindolocarbazoles | |
AU2003905978A0 (en) | A transfer line | |
AU2003902418A0 (en) | Timing device | |
AU2003900380A0 (en) | A device | |
AU2003905523A0 (en) | A Backseal Device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |